Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138057 · ClinicalTrials.gov registry record
BM Characterization Pilot
A clinical trial, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- 25
- Enrollment target
NCT03138057: Completed study, sponsored by Kimberly-Clark Corporation.
NCT03138057 is a clinical trial that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03138057 has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This is a prospective, pilot study to explore the relationship between an infant's nutrition, skin and stool composition at different ages.
Primary Outcome
enzyme levels and activity of infant stools
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2017-12-31 |
What the finished NCT03138057 record still lists
NCT03138057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03138057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03138057 about?
NCT03138057 is a clinical study titled "BM Characterization Pilot". This is a prospective, pilot study to explore the relationship between an infant's nutrition, skin and stool composition at different ages.
What is the current status of trial NCT03138057?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2017-05-01. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT03138057?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI